2018年

Parkinson病 : 新しい治療薬と最新の治療戦略
伊東秀文.神経治療学 35(3): 203-206, 2018
ドパミン作動薬 - 麦角系
石口宏, 伊東秀文.日本臨牀 76(増刊号4): 442-447, 2018.
A Prospective, Multicenter, Randomized Phase III Study to Evaluate the Efficacy and Safety of high dose Methylcobalamin for Amyotrophic Lateral Sclerosis (ALS): Protocol of Japan Early-stage Trial of high dose methylcobalamin for ALS(JETALS).
Oki R, Izumi Y, Nodera H, Sato Y, Nokihara H, Kanai K, Sonoo M, Urushitani M, Nishinaka K, Atsuta N, Kohara N, Shimizu T, Kikuchi H, Oda M, Ikeda K, Nagai M, Komai K, Kojima Y, Kuzume D, Isose S, Shimohama S, Abe K, Ito H, Noda K, Ishihara T, Morita M, Shimohata T, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R. JMIR Res Protoc. 2018 Dec 21;7(12):e12046. doi: 10.2196/12046. [Epub ahead of print]
Superficial siderosis associated with duplicated dura mater detected by CISS reverse MRI
Hosokawa M, Murata KY, Hironishi M, Koh J, Nishioka K, Nakao N, Ito H. J Neurol Sci. 2018 Sep 15;392:38-43. doi: 10.1016/j.jns.201807001. Epub 2018 Jul 5. PMID: 30097152
Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.
Maeki T, Tajima S, Kyaw AK, Matsumoto F, Miura K, Yamashita A, Yoshikawa A, Negishi K, Noguchi Y, Tadokoro K, Abe K, Taruya J, Koh J, Ito H, Ikegaya A, Abe F, Wada M, Nishigata T, Ikeda M, Kato F, Taniguchi S, Nakayama E, Takasaki T, Morita K, Lim CK, Saijo M. Jpn J Infect Dis. 2018 Sep 21;71(5):360-364. doi: 10.7883/yoken.JJID.2018.126. Epub 2018 Jun 29. PMID: 29962489
Antiepileptic Drugs Elevate Astrocytic Kir4.1 Expression in the Rat Limbic Region.
Mukai T, Kinboshi M, Nagao Y, Shimizu S, Ono A, Sakagami Y, Okuda A, Fujimoto M, Ito H, Ikeda A, Ohno Y. Front Pharmacol. 2018 Aug 6;9:845. doi: 10.3389/fphar.2018.00845. eCollection 2018. PMID: 30127740
Repeated hyperhidrosis and chilblain-like swelling with ulceration of the fingers and toes in hereditary sensory and autonomic neuropathy type II.
Shima T, Yamamoto Y, Kanazawa N, Murata KY, Ito H, Kondo T, Yuan J, Hashiguchi A, Takashima H, Furukawa F. J Dermatol. 2018 Apr 27. doi: 10.1111/1346-8138.14336. [Epub ahead of print] PMID: 29701257
Myotonic dystrophy type 1 with diabetes mellitus, mixed hypogonadism and adrenal insufficiency.
Takeshima K, Ariyasu H, Ishibashi T, Kawai S, Uraki S, Koh J, Ito H, Akamizu T. Endocrinol Diabetes Metab Case Rep. 2018 Jan 18;2018. pii: 17-0143. doi: 10.1530/EDM-17-0143. eCollection 2018. PMID: 29367875
Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations
Ayaki T, Ito H, Komure O, Kamada M, Nakamura M, Wate R, Kusaka H, Yamaguchi Y, Li F, Kawakami H, Urushitani M, Takahashi R. J Neuropathol Exp Neurol. 2018 Feb 1;77(2):128-138. doi: 10.1093/jnen/nlx109.
FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y, Ayaki T, Horibe T, Ito H, Takahashi R, Kawakami K. Brain Res. 2018 Feb 1;1680:39-45. doi: 10.1016/j.brainres.2017年12月01日2. Epub 2017 Dec 12.
紀伊ALSにおける免疫組織化学的検討
辻 郁在, 中山 宜昭, 綾木 孝, 廣西 昌也, 伊東 秀文 和歌山医学. 2018; 69(1): 14-19

PAGE TOP

AltStyle によって変換されたページ (->オリジナル) /